Literature DB >> 2863543

ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans.

R J Biggar, P L Gigase, M Melbye, L Kestens, P S Sarin, A J Bodner, P Demedts, W J Stevens, L Paluku, C Delacollette.   

Abstract

A serological survey of 250 outpatients in rural Zaire showed that the prevalence of antibody against HTLV-I, HTLV-II, and HTLV-III, as detected by enzyme-linked immunosorbent assay, correlated strongly with level of antibodies against Plasmodium falciparum. The age curve for the prevalence of antibody against these retroviruses and high titres of antibodies against P falciparum were similar. Tests with control sera obtained from HTLV-III seropositive homosexual men and American subjects repeatedly infected with malaria who had high antibody titres against P falciparum indicated that there was no cross-reactivity between P falciparum and these retroviruses. Immune-complex levels, but not IgG, IgM, or IgE levels, also correlated strongly with seropositivity in the ELISA HTLV-I and HTLV-III assay, although immune-complex-positive control samples were negative. Possible explanations include coincidental distribution paralleling malaria; similar mode of transmission; virus activation and/or enhanced antibody production due to the effect of malaria on the immune system; and false-positive reactivity in the ELISA assay due to cross-reactive antibodies or other unknown factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863543     DOI: 10.1016/s0140-6736(85)90461-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.

Authors:  R C Sanders; A Levin; G Anian; I Webber; H Lee; P Swanson; A Diwan; R Desowitz; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  HTLV-I infection in French West Indies: a case-control study.

Authors:  N Frery; M Chavance; I Valette; L Schaffar; C Neisson-Vernant; J Jouannelle; N Monplaisir
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

3.  Specificity of routine parasite serological tests in autoimmune disorders, neoplastic disease, EBV-induced mononucleosis, and HIV infection.

Authors:  W Kern; C Kirsten; P Förster; H J Diesfeld; E Vanek
Journal:  Klin Wochenschr       Date:  1987-10-01

Review 4.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

5.  Entamoeba histolytica antigen-specific induction of human immunodeficiency virus replication.

Authors:  S Croxson; D Mildvan; H Mathews; B J Poiesz
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

6.  Seroepidemiology of human immunodeficiency virus in Africa.

Authors:  I Wendler; J Schneider; B Gras; A F Fleming; G Hunsmann; H Schmitz
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

7.  Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia.

Authors:  O O Simooya; R M Mwendapole; S Siziya; A F Fleming
Journal:  BMJ       Date:  1988-07-02

8.  [Malaria tropica in HIV infection].

Authors:  T Weinke; W Scherer; H D Pohle
Journal:  Klin Wochenschr       Date:  1990-05-17

Review 9.  The natural history of human T lymphotropic virus-III infection: the cause of AIDS.

Authors:  M Melbye
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

10.  Screening of African sera stored for more than 17 years for HIV antibodies by site-directed serology.

Authors:  F Chiodi; G Biberfeld; E Parks; E Norrby; M Mufson
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.